• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项关于病程超过10年的2型糖尿病患者肌肉减少症及其与骨密度关系的研究。

A study of sarcopenia in patients with type 2 diabetes mellitus of more than 10 years duration and its association with bone mineral density.

作者信息

Parthasarathy B, K Kirubhakaran, Selvam S Pravin

机构信息

Department of General Medicine, Vinayaka Mission's Kirupananda Variyar Medical College and Hospitals (VMKVMCH), Vinayaka Mission's Research Foundation (DU), F Block Room No. 7 PG Boys Hostel, Chinnaseragapadi, Salem, Tamilnadu, 636308, India.

出版信息

Ir J Med Sci. 2025 Aug 6. doi: 10.1007/s11845-025-04050-y.

DOI:10.1007/s11845-025-04050-y
PMID:40767993
Abstract

INTRODUCTION

Diabetes mellitus is a growing global health concern, with an estimated 643 million individuals projected to be affected by 2030. Sarcopenia, once considered a normal part of aging, is now known to be associated with chronic diseases, including type 2 diabetes mellitus (T2DM). Muscle mass typically declines by approximately 8% per decade after age 40, accelerating to 15-25% per decade after age 70.

AIM

To determine the prevalence of sarcopenia in patients with T2DM of more than 10 years' duration and evaluate its association with bone mineral density (BMD).

METHODS

An observational study was conducted at a tertiary care hospital in Salem from January to October 2024. A total of 120 patients with T2DM for over 10 years were included. Data collected included demographics, medical history (fractures, comorbidities, use of insulin, bisphosphonates, or vitamin D supplements), and physical examination findings (weight, height, BMI, and blood pressure). Sarcopenia and BMD were assessed using dual-energy X-ray absorptiometry (DEXA).

RESULTS

The mean age of participants was 63.4 ± 8.7 years. Most had diabetes for 10-15 years (56.7%), and 32.5% had 16-20 years. The mean BMI was 25.7 ± 3.4 kg/m. Sarcopenia was present in 30.0% of participants. Additionally, 48.3% had osteopenia and 28.3% had osteoporosis.

CONCLUSION

Routine screening for sarcopenia and BMD in older adults with long-standing T2DM is essential for early intervention. Good glycemic control may help mitigate the risk of sarcopenia and related complications.

摘要

引言

糖尿病是一个日益引起全球健康关注的问题,预计到2030年将有6.43亿人受到影响。肌肉减少症曾被认为是衰老的正常组成部分,现在已知与包括2型糖尿病(T2DM)在内的慢性疾病有关。40岁以后,肌肉量通常每十年下降约8%,70岁以后加速至每十年下降15%-25%。

目的

确定病程超过10年的T2DM患者中肌肉减少症的患病率,并评估其与骨密度(BMD)的关系。

方法

2024年1月至10月在塞勒姆的一家三级护理医院进行了一项观察性研究。共纳入120例病程超过10年的T2DM患者。收集的数据包括人口统计学、病史(骨折、合并症、胰岛素、双膦酸盐或维生素D补充剂的使用情况)以及体格检查结果(体重、身高、BMI和血压)。使用双能X线吸收法(DEXA)评估肌肉减少症和BMD。

结果

参与者的平均年龄为63.4±8.7岁。大多数人患糖尿病10-15年(56.7%),32.5%的人患糖尿病16-20年。平均BMI为25.7±3.4kg/m。30.0%的参与者存在肌肉减少症。此外,48.3%的人患有骨质减少症,28.3%的人患有骨质疏松症。

结论

对长期患T2DM的老年人进行肌肉减少症和BMD的常规筛查对于早期干预至关重要。良好的血糖控制可能有助于降低肌肉减少症及相关并发症的风险。

相似文献

1
A study of sarcopenia in patients with type 2 diabetes mellitus of more than 10 years duration and its association with bone mineral density.一项关于病程超过10年的2型糖尿病患者肌肉减少症及其与骨密度关系的研究。
Ir J Med Sci. 2025 Aug 6. doi: 10.1007/s11845-025-04050-y.
2
Effectiveness and safety of vitamin D in relation to bone health.维生素D对骨骼健康的有效性与安全性。
Evid Rep Technol Assess (Full Rep). 2007 Aug(158):1-235.
3
A systematic review of the effectiveness of strategies for reducing fracture risk in children with juvenile idiopathic arthritis with additional data on long-term risk of fracture and cost of disease management.对降低幼年特发性关节炎患儿骨折风险策略的有效性进行系统评价,并提供关于骨折长期风险和疾病管理成本的额外数据。
Health Technol Assess. 2008 Mar;12(3):iii-ix, xi-xiv, 1-208. doi: 10.3310/hta12030.
4
Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.社区居住的老年人跌倒预防干预措施:系统评价和荟萃分析的益处、危害以及患者的价值观和偏好。
Syst Rev. 2024 Nov 26;13(1):289. doi: 10.1186/s13643-024-02681-3.
5
Association of Sarcopenic Obesity and Osteoporosis in Postmenopausal Women: Risk Factors and Protective Effects of Hormonal Therapy and Nutritional Status.绝经后女性肌少性肥胖与骨质疏松症的关联:激素治疗和营养状况的风险因素及保护作用
Arch Osteoporos. 2025 Jun 26;20(1):83. doi: 10.1007/s11657-025-01573-w.
6
Two-year follow-up study (PRIMROSE 3) to assess bone mineral density in subjects with uterine fibroids completing the PRIMROSE 1 and PRIMROSE 2 linzagolix trials.一项为期两年的随访研究(PRIMROSE 3),旨在评估完成PRIMROSE 1和PRIMROSE 2林扎戈利克斯试验的子宫肌瘤患者的骨矿物质密度。
Hum Reprod Open. 2025 May 13;2025(3):hoaf025. doi: 10.1093/hropen/hoaf025. eCollection 2025.
7
Glucocorticoid-induced osteoporosis: a systematic review and cost-utility analysis.糖皮质激素性骨质疏松症:一项系统评价与成本效用分析
Health Technol Assess. 2007 Mar;11(7):iii-iv, ix-xi, 1-231. doi: 10.3310/hta11070.
8
Low-carbohydrate versus balanced-carbohydrate diets for reducing weight and cardiovascular risk.低碳水化合物饮食与均衡碳水化合物饮食在减轻体重和降低心血管风险方面的比较。
Cochrane Database Syst Rev. 2022 Jan 28;1(1):CD013334. doi: 10.1002/14651858.CD013334.pub2.
9
Nutritional interventions for survivors of childhood cancer.儿童癌症幸存者的营养干预措施。
Cochrane Database Syst Rev. 2016 Aug 22;2016(8):CD009678. doi: 10.1002/14651858.CD009678.pub2.
10
Bisphosphonates for steroid-induced osteoporosis.双膦酸盐用于治疗类固醇诱导的骨质疏松症。
Cochrane Database Syst Rev. 2016 Oct 5;10(10):CD001347. doi: 10.1002/14651858.CD001347.pub2.

本文引用的文献

1
Prevalence of sarcopenia and its determinants in people with type 2 diabetes: Experience from a tertiary care hospital in north India.2 型糖尿病患者中肌少症的患病率及其决定因素:来自印度北部一家三级保健医院的经验。
Diabetes Metab Syndr. 2023 Dec;17(12):102902. doi: 10.1016/j.dsx.2023.102902. Epub 2023 Nov 11.
2
Sarcopenia: early prevention or overdiagnosis?肌肉减少症:早期预防还是过度诊断?
BMJ. 2022 Jan 13;376:e052592. doi: 10.1136/bmj-2019-052592.
3
Decreased handgrip strength in patients with type 2 diabetes: A cross-sectional study in a tertiary care hospital in north India.
2 型糖尿病患者握力下降:印度北部一家三级护理医院的横断面研究。
Diabetes Metab Syndr. 2021 Jan-Feb;15(1):325-329. doi: 10.1016/j.dsx.2021.01.007. Epub 2021 Jan 14.
4
Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment.亚洲肌少症工作组:2019年肌少症诊断与治疗共识更新
J Am Med Dir Assoc. 2020 Mar;21(3):300-307.e2. doi: 10.1016/j.jamda.2019.12.012. Epub 2020 Feb 4.
5
High brain natriuretic peptide is associated with sarcopenia in patients with type 2 diabetes: a cross-sectional study of KAMOGAWA-DM cohort study.高脑钠肽与 2 型糖尿病患者的肌肉减少症有关:神冈糖尿病队列研究的横断面研究。
Endocr J. 2019 Apr 25;66(4):369-377. doi: 10.1507/endocrj.EJ19-0024. Epub 2019 Apr 23.
6
Sarcopenia Is Recognized as an Independent Condition by an International Classification of Disease, Tenth Revision, Clinical Modification (ICD-10-CM) Code.肌肉减少症被国际疾病分类第十次修订本临床修订版(ICD-10-CM)编码确认为一种独立病症。
J Am Med Dir Assoc. 2016 Aug 1;17(8):675-7. doi: 10.1016/j.jamda.2016.06.001.
7
Where frailty meets diabetes.衰弱与糖尿病相遇之处。
Diabetes Metab Res Rev. 2016 Jan;32 Suppl 1:261-7. doi: 10.1002/dmrr.2743.
8
Prevalence, incidence, and clinical impact of sarcopenia: facts, numbers, and epidemiology-update 2014.肌肉减少症的流行率、发病率和临床影响:事实、数据和 2014 年的流行病学更新。
J Cachexia Sarcopenia Muscle. 2014 Dec;5(4):253-9. doi: 10.1007/s13539-014-0161-y. Epub 2014 Oct 22.
9
Sarcopenia: a predictor of mortality and the need for early diagnosis and intervention.肌肉减少症:死亡率的预测指标以及早期诊断和干预的必要性。
Aging Clin Exp Res. 2015 Jun;27(3):249-54. doi: 10.1007/s40520-014-0281-4. Epub 2014 Nov 4.
10
Sarcopenia: definition, epidemiology, and pathophysiology.肌肉减少症:定义、流行病学及病理生理学
J Bone Metab. 2013 May;20(1):1-10. doi: 10.11005/jbm.2013.20.1.1. Epub 2013 May 13.